Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a2633029aaffa53e

Jump to content

// Workers AI · dad joke modeWhat did CL 110,393 say to CL 110,392? "You're one byte behind.

From Wikipedia, the free encyclopedia

CL 110,393
Chemical and physical data
FormulaC32H32ClN3O3
Molar mass542.08 g·mol−1
3D model (JSmol)
  • Clc1cccc(c1)n1nccc1[C@H]1C[C@]23C=C[C@]1(OC)[C@@H]1Oc4c(O)ccc5C[C@H]2N(CC[C@]13c54)CC1CC1

CL 110,393 is an opioid drug derived from thebaine, closely related to the family of drugs known as the Bentley compounds which includes better known examples such as buprenorphine, etorphine and diprenorphine. Unlike most other related compounds, CL 110,393 acts as a highly selective κ-opioid receptor agonist with negligible activity at the μ-opioid receptor. It produces hallucinogenic effects with high potency and a long duration of action, as well as side effects such as dysphoria, tinnitus, slurred speech, ataxia, perspiration and tingling of the skin, and was investigated as a non-lethal incapacitating agent.[1][2][3]

See also

[edit]

References

[edit]
  1. Martin WR (1967). "Opioid Antagonists". Pharmacological Reviews. 19 (4): 463–521. doi:10.1016/S0031-6997(25)07161-3.
  2. Eddy NB, Martin WR (1970). "Drug Dependence of Specific Opiate Antagonist Type". Pharmacopsychiatry. 3 (2): 73–82. doi:10.1055/s-0028-1094264.
  3. Angrist B, Gershon S (May 1973). "Behavioral profile of a potent new psychotoxic compound". Psychopharmacologia. 30 (2): 109–116. doi:10.1007/BF00421425. PMID 4711368.